4//SEC Filing
Laumas Sandeep 4
Accession 0001789769-25-000087
CIK 0001789769other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:00 PM ET
Size
14.2 KB
Accession
0001789769-25-000087
Insider Transaction Report
Form 4
Laumas Sandeep
CFO and CBO
Transactions
- Sale
Common Stock
2025-09-10$23.88/sh−12,461$297,569→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-10−17,000→ 17,000 totalExercise: $11.60Exp: 2034-02-09→ Common Stock (17,000 underlying) - Exercise/Conversion
Common Stock
2025-09-10$11.60/sh+17,000$197,200→ 17,000 total - Exercise/Conversion
Common Stock
2025-09-10$12.68/sh+13,000$164,840→ 30,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-10−13,000→ 30,000 totalExercise: $12.68Exp: 2033-01-07→ Common Stock (13,000 underlying) - Sale
Common Stock
2025-09-10$23.04/sh−17,539$404,099→ 12,461 total
Footnotes (4)
- [F1]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
- [F3]Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter.
- [F4]Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter.
Documents
Issuer
Instil Bio, Inc.
CIK 0001789769
Entity typeother
Related Parties
1- filerCIK 0001721664
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:00 PM ET
- Size
- 14.2 KB